GO
Loading...

Allergan: The Unlikely Luxury Brand

Wednesday, 3 Aug 2011 | 7:10 PM ET

Let's play a game of word association, shall we? When I give you a word, write down the first brand(s) that come to mind.

OK. Here goes: the word is "luxury goods."

Allergan Grows on Product Strategy
Mad Money host Jim Cramer explains why Allergan isn't about to fall off a patent cliff like so many other big pharma companies. David Pyott, Allergan chairman, president & CEO weighs in on the company's earnings.

Alright. Did anyone come up with Allergan ?

When it comes to luxury, certainly few people think of health care. Yet several investment funds have recently added Allergan to their luxury goods portfolio and for good reason. The Irvine, Calif.-based company seems to do well wherever wealthy people are. Allergan's Botox, breast implants, eye-lash enlargers and dermal fillers that get rid of wrinkles are in high demand among the affluent population.

"I think when I reflect upon everything, it shows even in turbulent economic times, it's really the power of innovation that wins, especially with well-differentiated products," CEO David Pyott told Cramer on Wednesday's "Mad Money."

Cramer also spoke with Pyott about Allergan's future prospects and its latest earnings results. Watch the video to see the complete conversation.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
AEF
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.